<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02874508</url>
  </required_header>
  <id_info>
    <org_study_id>LeukoKAPE01</org_study_id>
    <nct_id>NCT02874508</nct_id>
  </id_info>
  <brief_title>Leukocytes and Perioperative Cardio Vascular Events</brief_title>
  <acronym>LeukoCAPE</acronym>
  <official_title>Association of Circulating Leukocyte Subpopulations and Cardio Vascular Events in the Perioperative Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To analyze whether non-cardiac surgery in high-risk cardio-vascular patients induces a
      quantitative change in one or several leukocyte subpopulations and whether such changes are
      associated with perioperative cardio-vascular events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Annually, there are more than 200 million surgeries worldwide (Weiser et al., 2016; Weiser et
      al., 2008). The POISE study revealed 5% of patients undergoing a non-cardiac surgery suffer
      perioperative myocardial infarcts going along with a perioperative mortality rate of about
      11,6% (Devereaux et al., 2011). Possibilities to preoperatively identify patients at risk are
      limited (Devereaux und Sessler, 2015; Gillmann et al., 2014) and prophylactic interventions
      are not yet established or controversial (Devereaux und Sessler, 2015).

      Selected leukocyte subpopulations have been demonstrated to be associated with higher risk
      for cardiovascular events (Berg et al., 2012; Cheng et al., 2008; Engelbertsen et al., 2012;
      Kotfis et al., 2015; Rogacev et al., 2011; Rogacev et al., 2012).The aim of this study is to
      analyze whether surgical stress (non-cardiac surgery) induces a quantitative change in one or
      several of these leukocyte subpopulations and whether quantitative changes are associated
      with perioperative cardiovascular events. Therefore, high-risk cardio-vascular patients
      scheduled for non-cardiac surgery will be recruited. Blood will be drawn at predefined time
      points before surgery and up to three days postoperatively. Leukocytes will be analyzed by
      flow cytometry. During 30 day follow up adverse cardiovascular events will be recorded. ECGs
      will be recorded preoperatively and on post-OP day 3. High-sensitive cardiac Troponin T will
      be measured prior to the operation and on post-OP day one to three. The patient chart will be
      screened for cardio vascular events up to day 30. A telephone interview will be performed to
      detect cardiovascular events after discharge until post-OP day 30.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Endpoint</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Composite of: cardiac death, myocardial ischemia, myocardial infarction, embolic or thrombotic stroke, congestive heart failure, serious cardiac arrhythmia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Individual components of the composite endpoint</measure>
    <time_frame>30 days postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral vascular occlusion</measure>
    <time_frame>30 days postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New onset atrial fibrillation</measure>
    <time_frame>30 days postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>30 days postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial injury after non-cardiac surgery</measure>
    <time_frame>30 days postoperative</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Elective Non-cardiac Surgery</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to University Hospital Heidelberg suffering coronary heart disease and
        scheduled for non-cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Coronary heart disease

          -  Non-cardiac surgery

          -  Inpatient treatment

          -  Informed consent

        Exclusion Criteria:

          -  17 years of age or younger

          -  Known pregnancy or breastfeeding

          -  Missing informed consent

          -  Ambulatory or day-case surgery

          -  Emergency surgery

          -  Acute or chronic leukemia

          -  Current leukocytosis

          -  Current aplasia or leukopenia

          -  Current GM-CSF treatment

          -  Carotid artery surgery

          -  History of splenectomy or indications of splenectomy

          -  Cortisone treatment within past 14 days

          -  History of organ transplantation

          -  Current immunosuppressive medication

          -  Chemotherapy completed less than 14 days ago

          -  Intraoperative dexamethasone application

          -  Entity which is part of the composite endpoint diagnosed within past 28 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johann Motsch, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anethesiology, University Hospital Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Große-Dunker G, Heisel I, Hornof F, Jeken J, Rebling NM, Ulrich C, Scheller B, Böhm M, Fliser D, Heine GH. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20. doi: 10.1016/j.jacc.2012.07.019. Epub 2012 Sep 19.</citation>
    <PMID>22999728</PMID>
  </reference>
  <reference>
    <citation>Berg KE, Ljungcrantz I, Andersson L, Bryngelsson C, Hedblad B, Fredrikson GN, Nilsson J, Björkbacka H. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet. 2012 Feb 1;5(1):122-31. doi: 10.1161/CIRCGENETICS.111.960385. Epub 2012 Jan 11.</citation>
    <PMID>22238190</PMID>
  </reference>
  <reference>
    <citation>Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, Leslie K, Rao-Melacini P, Chrolavicius S, Yang H, Macdonald C, Avezum A, Lanthier L, Hu W, Yusuf S; POISE (PeriOperative ISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011 Apr 19;154(8):523-8. doi: 10.7326/0003-4819-154-8-201104190-00003.</citation>
    <PMID>21502650</PMID>
  </reference>
  <reference>
    <citation>Devereaux PJ, Sessler DI. Cardiac Complications in Patients Undergoing Major Noncardiac Surgery. N Engl J Med. 2015 Dec 3;373(23):2258-69. doi: 10.1056/NEJMra1502824. Review.</citation>
    <PMID>26630144</PMID>
  </reference>
  <reference>
    <citation>Engelbertsen D, Andersson L, Ljungcrantz I, Wigren M, Hedblad B, Nilsson J, Björkbacka H. T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):637-44. doi: 10.1161/ATVBAHA.112.300871. Epub 2013 Jan 10.</citation>
    <PMID>23307873</PMID>
  </reference>
  <reference>
    <citation>Gillmann HJ, Meinders A, Grohennig A, Larmann J, Bünte C, Calmer S, Sahlmann B, Rustum S, Aper T, Lichtinghagen R, Koch A, Teebken OE, Theilmeier G. Perioperative levels and changes of high-sensitivity troponin T are associated with cardiovascular events in vascular surgery patients. Crit Care Med. 2014 Jun;42(6):1498-506. doi: 10.1097/CCM.0000000000000249.</citation>
    <PMID>24584063</PMID>
  </reference>
  <reference>
    <citation>Kotfis K, Biernawska J, Zegan-Barańska M, Żukowski M. Peripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy. Int J Mol Sci. 2015 May 4;16(5):10077-94. doi: 10.3390/ijms160510077.</citation>
    <PMID>25946343</PMID>
  </reference>
  <reference>
    <citation>Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J. 2011 Jan;32(1):84-92. doi: 10.1093/eurheartj/ehq371. Epub 2010 Oct 12.</citation>
    <PMID>20943670</PMID>
  </reference>
  <reference>
    <citation>Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008 Jul 12;372(9633):139-44. doi: 10.1016/S0140-6736(08)60878-8. Epub 2008 Jun 24.</citation>
    <PMID>18582931</PMID>
  </reference>
  <reference>
    <citation>Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad T, Chao TE, Berry WR, Gawande AA. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ. 2016 Mar 1;94(3):201-209F. doi: 10.2471/BLT.15.159293.</citation>
    <PMID>26966331</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>August 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2016</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Johann Motsch</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>leukocyte subpopulations</keyword>
  <keyword>perioperative myocardial infarction</keyword>
  <keyword>non-cardiac surgery</keyword>
  <keyword>perioperative cardiovascular risk</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

